GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Price-to-Tangible-Book

ME Therapeutics Holding (XCNQ:METX) Price-to-Tangible-Book : 70.86 (As of May. 21, 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Price-to-Tangible-Book?

As of today (2024-05-21), ME Therapeutics Holding's share price is C$4.11. ME Therapeutics Holding's Tangible Book per Share of Feb. 2024 for the quarter that ended in Feb. 2024 was C$0.06. Hence, ME Therapeutics Holding's Price to Tangible Book Ratio of today is 70.86.

The historical rank and industry rank for ME Therapeutics Holding's Price-to-Tangible-Book or its related term are showing as below:

XCNQ:METX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 29.41   Med: 52.64   Max: 75.86
Current: 68.5

During the past 2 years, ME Therapeutics Holding's highest Price to Tangible Book Ratio was 75.86. The lowest was 29.41. And the median was 52.64.

XCNQ:METX's Price-to-Tangible-Book is ranked worse than
98.7% of 1230 companies
in the Biotechnology industry
Industry Median: 2.78 vs XCNQ:METX: 68.50

A closely related ratio is called PB Ratio. As of today, ME Therapeutics Holding's share price is C$4.11. ME Therapeutics Holding's Book Value per Sharefor the quarter that ended in Feb. 2024 was C$0.06. Hence, ME Therapeutics Holding's P/B Ratio of today is 70.86.

ME Therapeutics Holding Price-to-Tangible-Book Historical Data

The historical data trend for ME Therapeutics Holding's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Price-to-Tangible-Book Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Price-to-Tangible-Book
- -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Price-to-Tangible-Book Get a 7-Day Free Trial - - - 29.41 75.86

Competitive Comparison of ME Therapeutics Holding's Price-to-Tangible-Book

For the Biotechnology subindustry, ME Therapeutics Holding's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ME Therapeutics Holding's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's Price-to-Tangible-Book falls into.


ME Therapeutics Holding Price-to-Tangible-Book Calculation

ME Therapeutics Holding's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Feb. 2024 )
=4.11/0.058
=70.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price to Tangible Book=Market Cap/Tangible Equity
=Market Cap/(Total Stockholders Equity-Preferred Stock-Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

ME Therapeutics Holding Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Price-to-Tangible-Book
Comparable Companies
Traded in Other Exchanges
Q9T:Germany
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
Website
https://www.metherapeutics.com
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines